Clinical Trials Browser

Completed × NIH × samarium Sm-153 lexidronam × Clear all

NCT00450619 2017-01-04

153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

Phase 2 Completed

44 enrolled 18 charts

Prostatic Neoplasms

NCT00316940 2013-09-20

Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell